[HTML][HTML] Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2022 - nature.com
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular psychiatry, 2022 - pubmed.ncbi.nlm.nih.gov
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

[HTML][HTML] Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2022 - ncbi.nlm.nih.gov
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2021 - europepmc.org
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The discovery of robust antidepressant actions
exerted by the< jats: italic> N</jats: italic>-methyl-D-aspartate receptor (NMDAR) antagonist …